نتایج جستجو برای: apc resistance

تعداد نتایج: 387193  

Journal: :Arteriosclerosis, thrombosis, and vascular biology 2016
Karen C Johnson Aaron K Aragaki Rebecca Jackson Alex Reiner Per Morten Sandset Jan Rosing Anders E A Dahm Frits Rosendaal JoAnn E Manson Lisa W Martin Simin Liu Lewis H Kuller Mary Cushman Jacques E Rossouw

OBJECTIVE To examine whether tissue factor pathway inhibitor or acquired activated protein C (APC) resistance influences the increased risk of coronary heart disease (CHD) due to estrogen plus progestin therapy. APPROACH AND RESULTS Prospective nested case-control study of 205 cases of CHD and 481 matched controls in the Women's Health Initiative randomized trial of estrogen plus progestin th...

Journal: :Thrombosis and haemostasis 1998
G Brandt R Gruppo C J Glueck D Stroop A Becker A Pillow P Wang

Very little data is available assessing the clinical utility of coagulation-based APC resistance assays compared to DNA-based analysis for the factor V Leiden mutation in children. Therefore, the clinical utility of four aPTT-based assays for APC resistance was evaluated in 169 children, ages 3 months through 16 years. The prevalence of the Arg506 to Gln mutation was 7/169 (4.1%). Using cutoff ...

Journal: :Cancer discovery 2017
Laurent Sansregret James O Patterson Sally Dewhurst Carlos López-García André Koch Nicholas McGranahan William Chong Hang Chao David J Barry Andrew Rowan Rachael Instrell Stuart Horswell Michael Way Michael Howell Martin R Singleton René H Medema Paul Nurse Mark Petronczki Charles Swanton

Intercellular heterogeneity, exacerbated by chromosomal instability (CIN), fosters tumor heterogeneity and drug resistance. However, extreme CIN correlates with improved cancer outcome, suggesting that karyotypic diversity required to adapt to selection pressures might be balanced in tumors against the risk of excessive instability. Here, we used a functional genomics screen, genome editing, an...

Journal: :Pathophysiology of haemostasis and thrombosis 2010
Thomas J Cramer John H Griffin Andrew J Gale

Coagulation factor V (FV) promotes inactivation of activated factor VIII (FVIIIa) by activated protein C (APC) and protein S. Loss of this APC cofactor activity is proposed to be partially responsible for the APC resistance phenotype of FV(Leiden). However, FVIIIa loses activity rapidly due to dissociation of the A2 domain, and this may be the primary mechanism of FVIIIa inactivation. APC/prote...

Journal: :Circulation 1999
S Kiechl A Muigg P Santer M Mitterer G Egger M Oberhollenzer F Oberhollenzer A Mayr A Gasperi W Poewe J Willeit

BACKGROUND The potential role of activated protein C (APC) resistance in arterial thrombosis and disease is a matter of ongoing controversy. METHODS AND RESULTS In the present population-based survey, a random sample of 826 men and women underwent high-resolution duplex ultrasound scanning of the carotid and femoral arteries. Response to APC was expressed in APC ratios. Subjects were tested f...

Journal: :Blood 1997
F Bernardi E M Faioni E Castoldi B Lunghi G Castaman E Sacchi P M Mannucci

Factor V gene polymorphisms were investigated to detect components that may contribute to the activated protein C (APC) resistance phenotype in patients with venous thromboembolism. A specific factor V gene haplotype (HR2) was defined by six polymorphisms and its frequency was found to be similar in normal subjects coming from Italy (0.08), India (0.1), and Somalia (0.08), indicating that it wa...

Journal: :Blood 1996
M Riewald G Hintz M Ritter M Schmidt A Neubauer H Riess

To the Editor: 70 nmol/L, 35 nmoUL, 14 nmollL, 7 nmol/L, and 0 nmol/L APC, corresponding to loo%, 50%, 20%, lo%, and 0% factor Va inactivaResistance to activated protein C (APC). caused by a mutated tion, respectively. Here we will summarize our current experience Coagulation factor v (factor v Leiden), has been reported as a prediswith this modified functional assay for the detection of factor...

Journal: :European journal of biochemistry 1999
M J Heeb A Rehemtulla M Moussalli Y Kojima R J Kaufman

Activated protein C (APC) cleavage of Factor Va (FVa) at residues R506 and R306 correlates with its inactivation. APC resistance and increased thrombotic risk are due to the mutation R506Q in Factor V (FV). To study the effects of individual cleavages in FVa by APC and the importance of regions near the cleavage sites, the following recombinant (r) human FVs were prepared and purified: wild-typ...

احمدی نژاد, مینو, احمدی, فرزانه, بشاش, داود, حمیدپور, محسن, ذوالفقاری, سیما, سلمان‌پور, زینال,

Background and Objective: Deep vein thrombosis (DVT) is one of the most common forms of venous thromboembolism (VTE). Deficiency in natural anticoagulant proteins is considered to be the major cause of thrombosis. In the present study, we investigated the incidence of defects in protein S, protein C, antithrombin and resistance to activated protein C (APC-R) in patients with DVT referred to the...

2002
Steven R. Lentz Donald J. Piegors José A. Fernández Rochelle A. Erger Erland Arning M. René Malinow John H. Griffin Teodoro Bottiglieri William G. Haynes Donald D. Heistad

Hyperhomocysteinemia has been proposed to inhibit the protein C anticoagulant system through 2 mechanisms: decreased generation of activated protein C (APC) by thrombin, and resistance to APC caused by decreased inactivation of factor Va (FVa). We tested the hypotheses that generation of APC by thrombin is impaired in hyperhomocysteinemia in monkeys and that hyperhomocysteinemia produces resist...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید